MedPath

Naloxone Hydrochloride

Approved
Approval ID

236349ef-2cb5-47ca-a3a5-99534c3a4996

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 20, 2022

Manufacturers
FDA

International Medication Systems, Limited

DUNS: 055750020

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Naloxone Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76329-1469
Application NumberANDA072076
Product Classification
M
Marketing Category
C73584
G
Generic Name
Naloxone Hydrochloride
Product Specifications
Route of AdministrationPARENTERAL
Effective DateNovember 18, 2016
FDA Product Classification

INGREDIENTS (1)

Naloxone HydrochlorideActive
Quantity: 1 mg in 1 mL
Code: F850569PQR
Classification: ACTIB

Naloxone Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76329-3369
Application NumberANDA072076
Product Classification
M
Marketing Category
C73584
G
Generic Name
Naloxone Hydrochloride
Product Specifications
Route of AdministrationPARENTERAL
Effective DateNovember 18, 2016
FDA Product Classification

INGREDIENTS (1)

Naloxone HydrochlorideActive
Quantity: 1 mg in 1 mL
Code: F850569PQR
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Naloxone Hydrochloride - FDA Drug Approval Details